At cancer diagnosis: A 'window of opportunity' for behavioural change towards physical activity. A randomised feasibility study in patients with colon and breast cancer

BMJ Open

Volumn 3, Issue 11, 2013, Pages

  Møller, Tom ^a   Lillelund, Christian ^a   Andersen, Christina ^a   Ejlertsen, Bent ^a   Nørgaard, Lone ^a   Christensen, Karl Bang ^b   Vadstrup, Eva ^a   Diderichsen, Finn ^b   Hendriksen, Carsten ^b   Bloomquist, Kira ^a   Adamsen, Lis ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; LIPID;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; BODY COMPOSITION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SCREENING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROMOTION; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; LEISURE; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; LUNG FUNCTION; MALE; MASSAGE; MUSCLE STRENGTH; PEDOMETRY; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; PHYSICAL INACTIVITY; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING;

EID: 84890334307     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003556     Document Type: Article

References (124)

1. Statens Seruminstitut. Cancerregistret: tal og analyser 2011 [The Danish Cancer Registry: figures and analysis 2011]. Copenhagen: SSI, 2012.
2. Storm HH, Engholm G, Hakulinen T, et al. Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006: a critical overview of the results. Acta Oncol 2010;49:532-44.
3. Andersen KG, Jensen MB, Kehlet H, et al. Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide. Acta Oncol 2012;51:1036-44.
4. Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain 2011;12:725-46.
5. Eckhoff L, Nielsen M, Moeller S, et al. TAX. Acta Oncol 2011;50:1075-82.
6. Saibil S, Fitzgerald B, Freedman OC, et al. Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey. Curr Oncol 2010;17:42-7.
7. Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 2008;134:700-41.
8. Mock V, Atkinson A, Barsevick A, et al. NCCN Practice Guidelines for cancer-related fatigue. Oncology (Williston Park) 2000;14 (11A):151 -61.
9. Stasi R, Abriani L, Beccaglia P, et al. Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 2003;98:1786-801.
10. Velthuis MJ, Agasi-Idenburg SC, Aufdemkampe G, et al. The effect of physical exercise on cancer-related fatigue during cancer treatment: a meta-analysis of randomised controlled trials. Clin Oncol (R Coll Radiol) 2010;22:208-21.
11. Navari RM. Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments. Drugs 2009;69:515-33.
12. Navari RM. Management of chemotherapy-induced nausea and vomiting: focus on newer agents and new uses for older agents. Drugs 2013;73:249-62.
13. Vance V, Mourtzakis M, McCargar L, et al. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 2011;12:282-94.
14. Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001;19:2381-9.
15. Allegra CJ, Yothers G, O'Connell MJ, et al. Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer. J Clin Oncol 2009;27:3385-90.
16. Qin YY, Li H, Guo XJ, et al. Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients. PLoS ONE 2011;6:e26946.
17. Brain E, Levy C, Serin D, et al. High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer. Br J Cancer 2011;105:1480-6.
18. Moebus V, Jackisch C, Lueck HJ, et al. Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. J Clin Oncol 2010;28:2874-80.
19. Midtgaard J, Baadsgaard MT, Moller T, et al. Self-reported physical activity behaviour; exercise motivation and information among Danish adult cancer patients undergoing chemotherapy. Eur J Oncol Nurs 2009;13:116-21.
20. Breen SJ, Baravelli CM, Schofield PE, et al. Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med J Aust 2009;190(Suppl 7): S99-104.
21. Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology 2001;10:19-28.
22. Cleeland CS. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr 2007;37:16-21.
23. Pinto BM, Eakin E, Maruyama NC. Health behavior changes after a cancer diagnosis: what do we know and where do we go from here? Ann Behav Med 2000;22:38-52.
24. Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010;42:1409-26.
25. Speck RM, Courneya KS, Masse LC, et al. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010;4:87-100.
26. Jones LW, Alfano CM. Exercise-oncology research: past, present, and future. Acta Oncol 2013;52:195-215.
27. Mishra SI, Scherer RW, Snyder C, et al. Exercise interventions on health-related quality of life for people with cancer during active treatment. Clin Otolaryngol 2012;37:390-2.
28. Mishra SI, Scherer RW, Snyder C, et al. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 2012;(8):CD008465.
29. Friedenreich CM, Gregory J, Kopciuk KA, et al. Prospective cohort study of lifetime physical activity and breast cancer survival. Int J Cancer 2009;124:1954-62.
30. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002;31:925-43.
31. Holmes MD, Chen WY, Feskanich D, et al. Physical activity and survival after breast cancer diagnosis. JAMA 2005;293:2479-86.
32. Meyerhardt JA, Giovannucci EL, Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006;24:3527-34.
33. Hawkes AL, Lynch BM, Owen N, et al. Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. Eur J Cancer 2011;47:267-76.
34. Herman DR, Ganz PA, Petersen L, et al. Obesity and cardiovascular risk factors in younger breast cancer survivors: the Cancer and Menopause Study (CAMS). Breast Cancer Res Treat 2005;93:13-23.
35. Jones LW, Haykowsky MJ, Swartz JJ, et al. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007;50:1435-41.
36. Lenihan DJ, Cardinale D, Cipolla CM. The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society. Prog Cardiovasc Dis 2010;53:88-93.
37. Mann DL, Krone RJ. Cardiac disease in cancer patients: an overview. Prog Cardiovasc Dis 2010;53:80-7.
38. Schmitz KH, Prosnitz RG, Schwartz AL, et al. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors. Cancer 2012;118(8 Suppl):2270-6.
39. Velthuis MJ, May AM, Koppejan-Rensenbrink RA, et al. Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial. BMC Cancer 2010;10:272.
40. Demark-Wahnefried W, Aziz NM, Rowland JH, et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005;23:5814-30.
41. Pinto BM, Maruyama NC, Clark MM, et al. Motivation to modify lifestyle risk behaviors in women treated for breast cancer. Mayo Clin Proc 2002;77:122-9.
42. Jones LW, Courneya KS, Peddle C, et al. Oncologists' opinions towards recommending exercise to patients with cancer: a Canadian national survey. Support Care Cancer 2005;13:929-37.
43. Adamsen L, Andersen C, Midtgaard J, et al. Struggling with cancer and treatment: young athletes recapture body control and identity through exercise: qualitative findings from a supervised group exercise program in cancer patients of mixed gender undergoing chemotherapy. Scand J Med Sci Sports 2009;19:55-66.
44. Jarden M, Nelausen K, Hovgaard D, et al. The effect of a multimodal intervention on treatment-related symptoms in patients undergoing hematopoietic stem cell transplantation: a randomized controlled trial. J Pain Symptom Manage 2009;38:174-90.
45. Midtgaard J, Rorth M, Stelter R, et al. The group matters: an explorative study of group cohesion and quality of life in cancer patients participating in physical exercise intervention during treatment. Eur J Cancer Care (Engl) 2006;15:25-33.
46. Midtgaard J, Stelter R, Rorth M, et al. Regaining a sense of agency and shared self-reliance: the experience of advanced disease cancer patients participating in a multidimensional exercise intervention while undergoing chemotherapy: analysis of patient diaries. Scand J Psychol 2007;48:181-90.
47. Moller T, Adamsen L. Hematologic patients ' clinical and psychosocial experiences with implanted long-term central venous catheter: self-management versus professionally controlled care. Cancer Nurs 2010;33:426-35.
48. Danish Health and Medicines Authority. Physical activity: recommendations for adults (18-64 years old). 2013. [cited 2013 July 3]. http://www.sst.dk/ English/Health-promotion/Physical-activity/Recommendations-for-adults.aspx
49. Danish Breast Cancer Cooperative Group. Randomized trial of epirubicin and cyclophosphamide followed by docetaxel against docetaxel and cyclophosphamide in patients with TOP2A normal early breast cancer. 2009. [cited 2013 July 3]. http://www.dbcg.dk/PDF%20Filer/07-READ%20Prtotokol%20161009.pdf
50. Cassidy J. SCOT - Short Course Oncology Therapy: a study of adjuvant chemotherapy in colorectal cancer by the CACTUS and QUASAR 3 Groups: RCTN59757862. 2013. [cited 2013 July 3]. http://www.controlled-trials.com/ ISRCTN59757862
51. Adamsen L, Quist M, Andersen C, et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 2009;339:b3410.
52. Jones LW, Eves ND, Haykowsky M, et al. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol 2008;9:757-65.
53. Leitzmann MF, Park Y, Blair A, et al . Physical activity recommendations and decreased risk of mortality. Arch Intern Med 2007;167:2453-60.
54. De Vries HA. Exercise intensity threshold for improvement of cardiovascular-respiratory function in older men. Geriatrics 1971;26:94-101.
55. Nordesjo LO. The effect of quantitated training on the capacity for short and prolonged work. Acta Physiol Scand Suppl 1974;405:1-54.
56. Davies CT, Knibbs AV. The training stimulus. The effects of intensity, duration and frequency of effort on maximum aerobic power output. Int Z Angew Physiol 1971;29:299-305.
57. Shephard RJ. Intensity, duration and frequency of exercise as determinants of the response to a training regime. Int Z Angew Physiol 1968;26:272-8.
58. Adamsen L, Midtgaard J, Rorth M, et al. Feasibility, physical capacity, and health benefits of a multidimensional exercise program for cancer patients undergoing chemotherapy. Support Care Cancer 2003;11:707-16.
59. World Health Organization. Global strategy on diet, physical activity and health: physical activity and adults: recommended levels of physical activity for adults aged 18-64 years. 2011. http://www.who.int/dietphysicalactivity/ factsheet-adults/en/index.html
60. Kwekkeboom KL, Hau H, Wanta B, et al. Patients' perceptions of the effectiveness of guided imagery and progressive muscle relaxation interventions used for cancer pain. Complement Ther Clin Pract 2008;14:185-94.
61. Luebbert K, Dahme B, Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology 2001;10:490-502.
62. Ferrell-Torry AT, Glick OJ. The use of therapeutic massage as a nursing intervention to modify anxiety and the perception of cancer pain. Cancer Nurs 1993;16:93-101.
63. Krustrup P, Hansen PR, Andersen LJ, et al. Long-term musculoskeletal and cardiac health effects of recreational football and running for premenopausal women. Scand J Med Sci Sports 2010;20(Suppl 1):58-71.
64. Krustrup P, Christensen JF, Randers MB, et al. Muscle adaptations and performance enhancements of soccer training for untrained men. Eur J Appl Physiol 2010;108:1247-58.
65. Krustrup P, Hansen PR, Randers MB, et al. Beneficial effects of recreational football on the cardiovascular risk profile in untrained premenopausal women. Scand J Med Sci Sports 2010;20(Suppl 1):40-9.
66. Pollock ML, Gaesser GA, Butcher JD, et al. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998;30:975-91.
67. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32(Suppl 9):S498-504.
68. Klarlund Petersen B. Skridttællerprogrammet [The walk-up programme]. 2008. . http://www.walk-up.dk/inspiration/skridttaelleren/13- skridttaellerprogrammet
69. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977;84:191-215.
70. Bandura A. Social cognitive theory: an agentic perspective. Annual Rev Psychol 2001;52:1-26.
71. Marcus BH, Rakowski W, Rossi JS. Assessing motivational readiness and decision making for exercise. Health Psychol 1992;11:257-61.
72. Marcus BH, Selby VC, Niaura RS, et al. Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 1992;63:60-6.
73. Marcus BH, Banspach SW, Lefebvre RC, et al. Using the stages of change model to increase the adoption of physical activity among community participants. Am J Health Promot 1992;6:424-9.
74. Prochaska JO, Norcross JC. Stages of change. Psychotherapy 2001;38:443-8.
75. Courneya KS, McKenzie DC, Reid RD, et al. Barriers to supervised exercise training in a randomized controlled trial of breast cancer patients receiving chemotherapy. Ann Behav Med 2008;35: 116-22.
76. Carlsen K, Dalton SO, Diderichsen F, et al. Risk for unemployment of cancer survivors: a Danish cohort study. Eur J Cancer 2008;44:1866-74.
77. Tønnesen H, Søndergaard L, Jørgensen T, et al. Terminologi: forebyggelse, sundhedsfremme og folkesundhed [Terminology: prevention, health promotion and public health]. Copenhagen: National Board of Health, 2005.
78. Midtgaard J, Christensen JF, Tolver A, et al. Efficacy of multimodal exercise-based rehabilitation on physical activity, cardiorespiratory fitness, and patient-reported outcomes in cancer survivors: a randomized, controlled trial. Ann Oncol 2013;24:2267-73.
79. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970;2:92-8.
80. Fairshter RD, Walters J, Salness K, et al. A comparison of incremental exercise tests during cycle and treadmill ergometry. Med Sci Sports Exerc 1983;15:549-54.
81. Saltin B, Astrand PO. Maximal oxygen uptake in athletes. J Appl Physiol 1967;23:353-8.
82. Buchele G, Och B, Bolte G, et al. Single vs. double data entry. Epidemiology 2005;16:130-1.
83. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
84. Sprangers MA, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996;14:2756-68.
85. Whistance RN, Conroy T, Chie W, et al. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 2009;45:3017-26.
86. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
87. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-38.
88. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
89. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77.
90. Snaith P. Anhedonia: exclusion from the pleasure dome. BMJ 1992;305:134.
91. Aadahl M, Jorgensen T. Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc 2003;35:1196-202.
92. Marcus BH, Rossi JS, Selby VC, et al. The stages and processes of exercise adoption and maintenance in a worksite sample. Health Psychol 1992;11:386-95.
93. Dahlem NW, Zimet GD, Walker RR. The Multidimensional Scale of Perceived Social Support: a confirmation study. J Clin Psychol 1991;47:756-61.
94. Galvao DA, Taaffe DR, Spry N, et al. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2010;28:340-7.
95. Winters-Stone KM, Dobek J, Nail L, et al. Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat 2011;127:447-56.
96. Pedersen BK. Body mass index-independent effect of fitness and physical activity for all-cause mortality. Scand J Med Sci Sports 2007;17:196-204.
97. Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun 2011;25:811-16.
98. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-20.
99. Nordestgaard BG, Zacho J. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander? Nutr Metab Cardiovasc Dis 2009;19:521-4.
100. Turner L, Shamseer L, Altman DG, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012;(11):MR000030.
101. Ajzen I. The theory of planned behaviour: reactions and reflections. Psychol Health 2011;26:1113-27.
102. Goffman E. Stigma: notes on the management of spoiled identity. New York: Simon & Schuster, 1986.
103. Giddens A. Modernity and self-identity: self and society in the late modern age. Cambridge: Polity Press, 1991.
104. Malterud K. Qualitative research: standards, challenges, and guidelines. Lancet 2001;358:483-8.
105. Barlow CE, Defina LF, Radford NB, et al. Cardiorespiratory fitness and long-term survival in 'low-risk' adults. J Am Heart Assoc 2012;1:e001354.
106. Gulati M, Black HR, Shaw LJ, et al . The prognostic value of a nomogram for exercise capacity in women. N Engl J Med 2005;353:468-75.
107. Mora S, Redberg RF, Cui Y, et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA 2003;290:1600-7.
108. Adamsen L, Midtgaard J, Andersen C, et al. Transforming the nature of fatigue through exercise: qualitative findings from a multidimensional exercise programme in cancer patients undergoing chemotherapy. Eur J Cancer Care (Engl) 2004;13:362-70.
109. Midtgaard J, Stage M, Moller T, et al. Exercise may reduce depression but not anxiety in self-referred cancer patients undergoing chemotherapy. Post-hoc analysis of data from the 'Body & Cancer' trial. Acta Oncol 2011;50:660-9.
110. Jones LW, Courneya KS, Mackey JR, et al. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol 2012;30:2530-7.
111. Berger AM, Grem JL, Visovsky C, et al. Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer. Oncol Nurs Forum 2010;37:E359-69.
112. Brem S, Kumar NB. Management of treatment-related symptoms in patients with breast cancer. Clin J Oncol Nurs 2011;15:63-71.
113. Glen H, Cassidy J. Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial. Expert Rev Anticancer Ther 2008;8:547-51.
114. Hutchinson AD, Hosking JR, Kichenadasse G, et al. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev 2012;38:926-34.
115. Carayol M, Bernard P, Boiche J, et al. Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed? Ann Oncol 2013;24:291-300.
116. Demark-Wahnefried W, Case LD, Blackwell K, et al. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer 2008;8:70-9.
117. Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 2007;25:4396-404.
118. Mock V, Frangakis C, Davidson NE, et al. Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology 2005;14:464-77.
119. Schwartz AL, Winters-Stone K, Gallucci B. Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 2007;34:627-33.
120. Segal R, Evans W, Johnson D, et al. Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 2001;19:657-65.
121. Gjerset GM, Fossa SD, Courneya KS, et al. Exercise behavior in cancer survivors and associated factors. J Cancer Surviv 2011;5:35-43.
122. Vallance JK, Courneya KS, Plotnikoff RC, et al. Analyzing theoretical mechanisms of physical activity behavior change in breast cancer survivors: results from the activity promotion (ACTION) trial. Ann Behav Med 2008;35:150-8.
123. Midtgaard J. Theoretical and practical outline of the Copenhagen PACT narrative-based exercise counselling manual to promote physical activity in post-therapy cancer survivors. Acta Oncol 2013;52:303-9.
124. Underwood JM, Townsend JS, Stewart SL, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors - Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ 2012;61:1-23.